Apoptosis Activator 2,
79183-19-0,
1-(3,4-Dichlorobenzyl)-1H-indole-2,3-dione,
Apoptosis Activator II,
1-(3,4-dichlorobenzyl)indoline-2,3-dione,
MDK83190,
AK326219,
1-[(3,4-dichlorophenyl)methyl]indole-2,3-dione,
J-503075,
1H-Indole-2,3-dione,1-[(3,4-dichlorophenyl)methyl]-,
SR-01000411093,
ApoptosisActivator2,
apoptosis-activator-2,
AC1LYJSJ,
Tocris-2098,
AC1Q3JHQ,
CBMicro_042945,
Isatin-based compound, 16,
CHEMBL375126,
SCHEMBL5426477,
BDBM22796,
CHEBI:92273,
cid_1901244,
CTK5E6556,
KS-00001DBG,
AOB2639,
DTXSID30365533,
EX-A147,
HMS3268L07,
HMS3651L12,
HMS3677G05,
BCP06746,
ZINC2276110,
BS0033,
HSCI1_000276,
IN1411,
MFCD00141556,
STK215768,
AKOS000448309,
CS-3545,
MCULE-9372937110,
RL05057,
NCGC00025353-01,
11E-386S,
HY-18633,
SC-94599,
BIM-0043056.P001,
AB0205176,
FT-0732905,
S2927,
SW219926-1,
Y0436,
EC-000.2382,
MLS-0469602.0001,
N-(3,4-dichlorobenzyl)-1h-indole-2,3-dione,
S-7787,
AB00102233-01,
SR-01000411093-1,
SR-01000411093-2,
BRD-K15164005-001-01-5,
BRD-K15164005-001-02-3,
1-[(3,4-dichlorophenyl)methyl]-2,3-dihydro-1H-indole-2,3-dione,
D07EDG,
C15H9Cl2NO2,
cc-650,
1- -1H-indole-2,3-dione,
ZINC02276110,
ACN-029597,
CID1901244,
A4016,
A11944,
1-[(3,4-Dichlorophenyl)methyl]-1H-indole-2,3-dione,
1H-Indole-2,3-dione, 1-[(3,4-dichlorophenyl)methyl]-,
Apoptosis Activator 2, 97%, a cytochrome c caspase activator and apoptosis inducer - 1MG 1mg,